Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven movement of the legs and upper extremities. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Frequently asked questions
What sector does Onward Medical N.V. (ONWD) operate in?
Onward Medical N.V. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Onward Medical N.V. (ONWD) current stock price?
As of the latest data, Onward Medical N.V. stock price is €2.07, with a previous close of €2.07. Onward Medical N.V. lost -€0.01 in the last trading session, representing a -0.24% loss.
What is Onward Medical N.V. (ONWD) current market capitalization?
Onward Medical N.V. market cap is approximately 143.58 million.
What is Onward Medical N.V. (ONWD) Earnings Per Share (EPS)?
The trailing EPS is -€0.85, and the forward EPS is -€0.60.
What is Onward Medical N.V. (ONWD) EBITDA?
Onward Medical N.V. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -23.40 million.
Does Onward Medical N.V. (ONWD) pay dividends?
No. Onward Medical N.V. does not pay a dividend.
When is Onward Medical N.V. (ONWD) next earnings report?
Onward Medical N.V. is expected to release its next earnings report on December 31, 2026.
What is Onward Medical N.V. (ONWD) beta (volatility) score?
Onward Medical N.V. has a beta of 0.807, meaning its volatility is roughly in line with the market.
